Paper26322900
Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
Guo F and 4 others. ACS Appl Mater Interfaces, 2015. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes. Papers, record 26322900. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26322900
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Carriers | Major topic |
| Folic Acid | Major topic |
| Hyperthermia, Induced | Major topic |
| Indoles | Major topic |
| Nanoparticles | Major topic |
| Neoplasms | Major topic |
| Theranostic Nanomedicine | Major topic |
| Titanium | Major topic |
| Animals | |
| Binding, Competitive | |
| Cell Death | |
| Cell Line, Tumor | |
| Doxorubicin | |
| Drug Delivery Systems | |
| Female | |
| Humans | |
| Liposomes | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Microbubbles | |
| Particle Size | |
| Phototherapy | |
| Surface Properties | |
| Temperature | |
| Tissue Distribution | |
| Treatment Outcome |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41717824 | Ejecta-Modulated Bubble Dynamics Play a Dominant Role in Stone Retropulsion. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41717824 | PubMed |
| 41129032 | Bioorthogonal liposome-based sequential drug delivery system for enhanced tumor accumulation and targeted therapy. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/41129032 | PubMed |
| 39725974 | Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39725974 | PubMed |
| 39309187 | EGFR-Targeted and NIR-Triggered Lipid-Polymer Hybrid Nanoparticles for Chemo-Photothermal Colorectal Tumor Therapy. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/39309187 | PubMed |
| 38454419 | The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38454419 | PubMed |
| 38407670 | Theranostics: a multifaceted approach utilizing nano-biomaterials. | Discov Nano | 2024 | https://conductscience.org/library/papers/38407670 | PubMed |
| 38276487 | Targeted PLGA-Chitosan Nanoparticles for NIR-Triggered Phototherapy and Imaging of HER2-Positive Tumors. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38276487 | PubMed |
| 36839765 | Photothermal Properties of IR-780-Based Nanoparticles Depend on Nanocarrier Design: A Comparative Study on Synthetic Liposomes and Cell Membrane and Hybrid Biomimetic Vesicles. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839765 | PubMed |
| 35697894 | Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/35697894 | PubMed |
| 35659113 | NIR-Mediated drug release and tumor theranostics using melanin-loaded liposomes. | Biomater Res | 2022 | https://conductscience.org/library/papers/35659113 | PubMed |
| 35548210 | Mitochondria targeting IR780-based nanoGUMBOS for enhanced selective toxicity towards cancer cells. | RSC Adv | 2018 | https://conductscience.org/library/papers/35548210 | PubMed |
| 35541810 | Magnetically targeted nanoparticles for imaging-guided photothermal therapy of cancer. | RSC Adv | 2019 | https://conductscience.org/library/papers/35541810 | PubMed |
| 35540567 | Near-infrared-induced IR780-loaded PLGA nanoparticles for photothermal therapy to treat breast cancer metastasis in bones. | RSC Adv | 2019 | https://conductscience.org/library/papers/35540567 | PubMed |
| 35335518 | Nanocluster-Based Drug Delivery and Theranostic Systems: Towards Cancer Therapy. | Polymers (Basel) | 2022 | https://conductscience.org/library/papers/35335518 | PubMed |
| 34550040 | Topically applied liposome-in-hydrogels for systematically targeted tumor photothermal therapy. | Drug Deliv | 2021 | https://conductscience.org/library/papers/34550040 | PubMed |
| 32642819 | Dual-pH Sensitive Charge-Reversal Drug Delivery System for Highly Precise and Penetrative Chemotherapy. | Pharm Res | 2020 | https://conductscience.org/library/papers/32642819 | PubMed |
| 32104466 | Current developments in drug delivery with thermosensitive liposomes. | Asian J Pharm Sci | 2019 | https://conductscience.org/library/papers/32104466 | PubMed |
| 31635367 | Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/31635367 | PubMed |
| 31360117 | Molecular Mechanism for Selective Cytotoxicity towards Cancer Cells of Diselenide-Containing Paclitaxel Nanoparticles. | Int J Biol Sci | 2019 | https://conductscience.org/library/papers/31360117 | PubMed |
| 31118609 | IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer. | Int J Nanomedicine | 2019 | https://conductscience.org/library/papers/31118609 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26322900
GET https://conductscience.org/api/papers/v1/26322900/cited_by?page=2